The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot

BACKGROUND: In England, bivalent vaccination (Cervarix) against high-risk human papillomavirus (HR-HPV) genotypes 16/18 was offered in a population-based catch-up campaign in 2008–2010 to girls aged 14–17 years. These women are now entering the national cervical screening programme. We determined th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebolj, Matejka, Pesola, Francesca, Mathews, Christopher, Mesher, David, Soldan, Kate, Kitchener, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296648/
https://www.ncbi.nlm.nih.gov/pubmed/35347326
http://dx.doi.org/10.1038/s41416-022-01791-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296648/
https://www.ncbi.nlm.nih.gov/pubmed/35347326
http://dx.doi.org/10.1038/s41416-022-01791-w

Ejemplares similares